Investment firms British Business Bank commits €25 million to EQT Life Science’s Health Economics 3 Fund dedicated to commercial stage medtech and digital health technologies Andera Partners raised €430 million for its Ander Expansion IV fund to invest in companies leading the way on ESG issues Asabys Partners joined The European Life Science Coalition (ELSC) as an Associate Member, alongside existing members Novo Holdings, Sofinnova Partners, […]
Last month I went to Copenhagen for the LSX Nordic conference, which was great. The metro ride from the airport to the city centre in a driverless train was a novelty for me, as tube trains on the London Underground all have drivers. I thought no more about it. What if, though, the aeroplane in […]
ARE vaccines coming in from the cold? That’s the question this week after Eli Lilly splashed out almost $4 billion on three vaccine biotechs, two of which are in the early stage of clinical development. All are developing jabs for or related to infectious diseases. Why’s this a big deal? Because everyone knows that […]
Progress for our clients in the clinic this week, with Mestag Therapeutics dosing the first patient in their STARLYS clinical trial and STORM Therapeutics to present data on its dose escalation study at ASCO later this month. More good news, as Hansa Biopharma entered a multi-million-Euro licensing agreement with SERB S.A. Bring on the bank […]
